Partners In Practice Articles
Improving Clinical Practice Through Education: A Case Study of Online CME on Metastatic Renal Cell Carcinoma
Between February 6, 2014 and March 15, 2014 a total of 529 physicians, nurse practitioners, physician assistants, nurses, pharmacists and medical students participated in the online CME activity “Optimizing Dose Intensity for Patients with Metastatic Renal Cell Carcinoma.”
Survival Advantage with Frontline Docetaxel in Combination With Hormone Deprivation Therapy in Hormone Sensitive Prostate Cancer
Targeting Anaplastic Lymphoma Kinase (ALK) gene in Non-Small Cell Lung Cancer
Research Spotlight: Liver Cancer
The Expanding Role of Interventional Radiology in the Management of Primary Liver Tumors
The management of hepatocellular carcinoma (HCC) requires a careful multidisciplinary approach utilizing medical oncologists, surgeons and interventional radiologists. Treatment options require assessment of tumor stage, liver function and performance status.
NanoKnife Offers Promising Treatment Option for Locally Unresectable Pancreas Tumors
by Boris Kuvshinoff II, MD, MBA
Chief Medical Officer, Professor of Oncology
Targeting the Microenvironment in Pancreatic Cancer
Pancreatic cancer is a highly desmoplastic disease. Microscopically, the nests of cancer cells are surrounded by thick and abundant stromal tissue that is constituted by collagen, fibroblasts, stellate cells, inflammatory infiltrate and endothelial cells.
New “Information Card” Prepares Biliary Cancer Patients and Medical Personnel for Emergency Situations
Preserving Quality of Life for Surgical Colorectal Cancer Patients
Steven Hochwald, MD, FACS, Chief of Gastrointestinal Surgery and Vice Chair of Surgical Oncology, explains how our comprehensive, multidisciplinary team approach to treating colorectal cancer helps preserve quality of life for our surgical patients.
Hope for Metastatic Colorectal Cancer Patients
Renuka Iyer, MD, Co-Director, Liver and Pancreas Tumor Program and Section Chief for Gastrointestinal Oncology, describes how research and clinical trials are offering renewed hope to patients with metastatic colorectal cancer.